SCHEMBL23068576

SCHEMBL23068576

CC1(Nc2nc(Cl)nc3c2[S@+]([O-])CC3)CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30607036 1.00 — —
SCHEMBL22734114 1.00 — —
SCHEMBL26968832 0.97 — —
SCHEMBL22734118 0.94 — —
SCHEMBL30686999 0.81 PDE4A (0.41) —
SCHEMBL30639341 0.81 LATS1 (0.32) —
SCHEMBL30639342 0.81 LATS1 (0.32) —
SCHEMBL31571836 0.81 LATS1 (0.32) —
SCHEMBL14734142 0.81 LATS1 (0.32) —
SCHEMBL29138589 0.81 PDE4A (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3724194-B1 SUBSTITUTED AZETIDINE DIHYDROTHIENOPYRIMIDINES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS UNION THERAPEUTICS AS (DK) 2023-12-27 — — EP disclosed
CN-111712502-B Substituted azetidine dihydro-thienopyrimidines and their use as phosphodiesterase inhibitors 联合疗法公司 2023-10-27 — — CN disclosed
US-11292799-B2 Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors UNION therapeutics A/S (DK) 2022-04-05 — — US disclosed
US-20210070769-A1 SUBSTITUTED AZETIDINE DIHYDROTHIENOPYRIMIDINES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS UNION therapeutics A/S (DK) 2021-03-11 — — US disclosed
US-20210070769-A1 SUBSTITUTED AZETIDINE DIHYDROTHIENOPYRIMIDINES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS UNION therapeutics A/S (DK) 2021-03-11 — — US disclosed
CN-111712502-A Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors 利奥制药有限公司 2020-09-25 — — CN disclosed
Send feedback